Carolina Sánchez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Carolina Sánchez has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
A Fernández‐Cruz
Preventive Medicine Department University Hospital Clínico San Carlos Madrid Spain
1 shared publication- Ana García-Martínez
Emergency Department, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Catalonia, Spain
1 shared publication Beatriz López-Barbeito
Emergency Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain; The GREAT (Global Research on Acute Conditions Team) Network, Rome, Italy
1 shared publicationBlanca Coll-Vinent
Emergency Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain
1 shared publicationCarlos Cardozo
Emergency Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain; Emergency Department, Hospital Universitario Austral, Buenos Aires, Argentina
1 shared publicationChristian Müller
The GREAT (Global Research on Acute Conditions Team) Network, Rome, Italy; Cardiovascular Research Institute Basel (CRIB) and Cardiology Department, University Hospital Basel, Basel Switzerland
1 shared publication
Latest Publications
- Open Access
- 1 March 2022
- Published by Elsevier in Patient Education and Counseling
- Vol. 105 (3) , 695-706
Factors associated with late presentation to the emergency department in patients complaining of chest pain
- 1 March 2022
- Published by Elsevier in Patient Education and Counseling
- Vol. 105 (3) , 695-706
Open AccessFactors associated with late presentation to the emergency department in patients complaining of chest pain
- Open Access
- 6 September 2013
- Published by Wiley in HIV Medicine
- Vol. 15 (1) , 40-49
The CD4:CD8 ratio is associated with markers of age‐associated disease in virally suppressed HIV‐infected patients with immunological recovery
Objectives: Inversion of the CD4:CD8 ratio (< 1) has been identified as a hallmark of inmmunosenescence and an independent predictor of mortality in the general population. We aimed to assess the association between the CD4:CD8 ratio and markers of age‐associated disease in treated HIV‐infected patients with good immunovirological response.Methods: A cross‐sectional analysis was conducted in 132 HIV‐infected adults on antiretroviral therapy (ART), with plasma HIV RNA < 50 HIV‐1 RNA copies/mL for at least 1 year, CD4 count > 350 cells/μL and age < 65 years. We analysed the associations between the CD4:CD8 ratio and subclinical atherosclerosis [assessed using carotid intima‐media thickness (IMT)], arterial stiffness [assessed using the augmentation index (AIx)], the estimated glomerular filtration rate (eGFR), muscle wasting and sarcopenia [assessed using appendicular lean mass/height2 (ALM) measured by dual‐energy X‐ray absorptiometry (DEXA)].Results: CD4:CD8 ratio inversion was associated with higher IMT, lower eGFR and lower ALM (all values P < 0.05), but not with AIx. In multivariate analyses adjusted for age, sex, hypertriglyceridaemia, tobacco use and cumulative ART exposure, inversion of the CD4:CD8 ratio was independently associated with higher IMT [odds ratio (OR) 2.9; 95% confidence interval (CI) 1.2–7.1], arterial stiffness (OR 4.8; 95% CI 1.0–23.5) and lower eGFR (OR 5.2; 95% CI 1.0–64.4), but not sarcopenia (OR 0.7; 95% CI 0.2–2.7). These associations persisted when models were applied to subjects with nadir CD4 counts > 200 cells/μL and those with CD4 counts > 500 cells/μL.Conclusions: The CD4:CD8 ratio in treated HIV‐infected subjects with good immunovirological response is independently associated with markers of age‐associated disease. Hence, it might be a clinically useful predictor of non‐AIDS‐defining conditions.
- 6 September 2013
- Published by Wiley in HIV Medicine
- Vol. 15 (1) , 40-49
Open AccessThe CD4:CD8 ratio is associated with markers of age‐associated disease in virally suppressed HIV‐infected patients with immunological recovery
Objectives: Inversion of the CD4:CD8 ratio (< 1) has been identified as a hallmark of inmmunosenescence and an independent predictor of mortality in the general population. We aimed to assess the association between the CD4:CD8 ratio and markers of age‐associated disease in treated HIV‐infected patients with good immunovirological response.Methods: A cross‐sectional analysis was conducted in 132 HIV‐infected adults on antiretroviral therapy (ART), with plasma HIV RNA < 50 HIV‐1 RNA copies/mL for at least 1 year, CD4 count > 350 cells/μL and age < 65 years. We analysed the associations between the CD4:CD8 ratio and subclinical atherosclerosis [assessed using carotid intima‐media thickness (IMT)], arterial stiffness [assessed using the augmentation index (AIx)], the estimated glomerular filtration rate (eGFR), muscle wasting and sarcopenia [assessed using appendicular lean mass/height2 (ALM) measured by dual‐energy X‐ray absorptiometry (DEXA)].Results: CD4:CD8 ratio inversion was associated with higher IMT, lower eGFR and lower ALM (all values P < 0.05), but not with AIx. In multivariate analyses adjusted for age, sex, hypertriglyceridaemia, tobacco use and cumulative ART exposure, inversion of the CD4:CD8 ratio was independently associated with higher IMT [odds ratio (OR) 2.9; 95% confidence interval (CI) 1.2–7.1], arterial stiffness (OR 4.8; 95% CI 1.0–23.5) and lower eGFR (OR 5.2; 95% CI 1.0–64.4), but not sarcopenia (OR 0.7; 95% CI 0.2–2.7). These associations persisted when models were applied to subjects with nadir CD4 counts > 200 cells/μL and those with CD4 counts > 500 cells/μL.Conclusions: The CD4:CD8 ratio in treated HIV‐infected subjects with good immunovirological response is independently associated with markers of age‐associated disease. Hence, it might be a clinically useful predictor of non‐AIDS‐defining conditions.